Protalix BioTherapeutics (PLX) Tax Rate (2023 - 2026)
Protalix BioTherapeutics (PLX) posted Tax Rate of 22.28% for Q2 2026, up 66.82% on a QoQ basis from 13.36% in Q1 2026, and down 5291.0% year-over-year from 0.43% in Q2 2025.
Powered by 
Analysis
Protalix BioTherapeutics (PLX) Tax Rate (2023 - 2026) Analysis & Trends
Protalix BioTherapeutics has reported Tax Rate for 4 years, with the latest figure at 22.28% in Q2 2026.
- On a quarterly basis, Tax Rate fell 5291.0% year-over-year to 22.28% in Q2 2026; TTM through Jun 2026 was 9.74%, a 461.0% decrease from a year earlier, with the FY2025 full-year figure at 21.01%, up 696.0% from the prior year.
- Tax Rate was 22.28% for Q2 2026 at Protalix BioTherapeutics, up from 13.36% in the prior quarter.
- The five-year high for Tax Rate was 75.19% in Q2 2025, with the low at 60.16% in Q4 2023.
- Average Tax Rate over 4 years is 7.71%, with a median of 4.98% recorded in 2024.
- The sharpest annual moves came in 2025 and 2026: Tax Rate surged 7215 bps in 2025, then plunged 5291 bps in 2026.
- Over 4 years, Tax Rate stood at 60.16% in 2023, then jumped by 112 bps to 6.93% in 2024, then jumped by 337 bps to 30.28% in 2025, then slipped by 26 bps to 22.28% in 2026.
- The last three Tax Rate figures came in at 22.28% (Q2 2026), 13.36% (Q1 2026), and 30.28% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.74 Bn | 192.75 Bn | 7.24 Bn | 14.20% |
| 2 | Gilead Sciences | 179.96 Bn | 176.78 Bn | 6.22 Bn | -2.36% |
| 3 | Vertex Pharmaceuticals | 131.20 Bn | 123.35 Bn | 2.84 Bn | 20.98% |
| 4 | Regeneron Pharmaceuticals | 82.05 Bn | 74.05 Bn | 3.93 Bn | 15.11% |
| 5 | Argenx Se | 60.28 Bn | 55.10 Bn | 1.37 Bn | -10.89% |
| 6 | Moderna | 53.67 Bn | 48.54 Bn | 52.00 Mn | -1.96% |
| 7 | Alnylam Pharmaceuticals | 33.08 Bn | 29.78 Bn | 992.69 Mn | 7.49% |
| 8 | Biogen | 31.91 Bn | 30.62 Bn | 1.96 Bn | 26.36% |
| 9 | Roivant Sciences | 29.22 Bn | 29.22 Bn | 1.16 Mn | 1.34% |
| 10 | Protalix BioTherapeutics | 217.96 Mn | 177.31 Mn | 12.13 Mn | 22.28% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.28% |
| Mar 31, 2026 | 13.36% |
| Dec 31, 2025 | 30.28% |
| Sep 30, 2025 | -7.82% |
| Jun 30, 2025 | 75.19% |
| Mar 31, 2025 | 3.03% |
| Dec 31, 2024 | 6.93% |
| Sep 30, 2024 | 15.79% |
| Jun 30, 2024 | 3.04% |
| Mar 31, 2024 | 2.92% |
| Dec 31, 2023 | -60.16% |
| Sep 30, 2023 | -7.74% |
| Jun 30, 2023 | 17.50% |
| Mar 31, 2023 | -6.64% |